Amundi
AMRX icon

Amundi’s Amneal Pharmaceuticals AMRX Stock Holding History

Amundi’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$690K Buy
+39,890
New +$547K ﹤0.01% 1523
2026
Q1 		– Sell
-45,463
Closed -$573K – 2040
2025
Q4 		$573K Buy
+45,463
New +$520K ﹤0.01% 1426
2025
Q3 		– Sell
-46,392
Closed -$388K – 1594
2025
Q2 		$388K Buy
46,392
+14,628
+46% +$110K ﹤0.01% 1438
2025
Q1 		$248K Hold
31,764
– – ﹤0.01% 1639
2024
Q4 		$256K Buy
+31,764
New +$266K ﹤0.01% 1689

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Amundi's AMRX Position: Q2 2026 in Review

Amundi opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 39,890 shares worth $690K. The stake represents ﹤0.01% of the portfolio and ranks #1523 among its holdings. This is a return to the name: Amundi previously reported a position in AMRX as recently as Q4 2025.

Amundi first reported a position in AMRX in Q4 2024 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Amundi held 39,890 shares of Amneal Pharmaceuticals worth $690K as of Q2 2026.
  • Amneal Pharmaceuticals was a new Amundi position in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1523 holding.
  • Amundi first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.